Psyence Group Stock Performance
| PSYGF Stock | USD 0.13 0.00 0.00% |
The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and Psyence are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Psyence Group has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical and fundamental indicators, Psyence is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 124.5 K | |
| Total Cashflows From Investing Activities | -311.5 K |
Psyence |
Psyence Relative Risk vs. Return Landscape
If you would invest 13.00 in Psyence Group on November 21, 2025 and sell it today you would earn a total of 0.00 from holding Psyence Group or generate 0.0% return on investment over 90 days. Psyence Group is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Psyence, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Psyence Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Psyence for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Psyence Group can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Psyence Group generated a negative expected return over the last 90 days | |
| Psyence Group has some characteristics of a very speculative penny stock | |
| Psyence Group has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (4.6 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Psyence Group has accumulated about 2.32 M in cash with (3.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03. | |
| Latest headline from finance.yahoo.com: Acquisition by Dean Li of 15087 shares of Merck at 56.04 subject to Rule 16b-3 |
Psyence Fundamentals Growth
Psyence Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Psyence, and Psyence fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Psyence Pink Sheet performance.
| Return On Equity | -1.66 | |||
| Return On Asset | -0.74 | |||
| Operating Margin | (787.36) % | |||
| Current Valuation | 7.17 M | |||
| Shares Outstanding | 93.28 M | |||
| Price To Book | 1.93 X | |||
| Price To Sales | 1,359 X | |||
| EBITDA | (4.55 M) | |||
| Cash And Equivalents | 2.32 M | |||
| Cash Per Share | 0.03 X | |||
| Total Debt | 1.32 M | |||
| Debt To Equity | 0.84 % | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | (3.56 M) | |||
| Earnings Per Share | (0.14) X | |||
| Total Asset | 4.35 M | |||
About Psyence Performance
By analyzing Psyence's fundamental ratios, stakeholders can gain valuable insights into Psyence's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Psyence has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Psyence has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Psyence Group Inc., a life science biotechnology company, engages in the commercial psilocybin mushroom cultivation and production activities. Psyence Group Inc. was founded in 2019 and is based in Toronto, Canada. Psyence is traded on OTC Exchange in the United States.Things to note about Psyence Group performance evaluation
Checking the ongoing alerts about Psyence for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Psyence Group help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Psyence Group generated a negative expected return over the last 90 days | |
| Psyence Group has some characteristics of a very speculative penny stock | |
| Psyence Group has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (4.6 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Psyence Group has accumulated about 2.32 M in cash with (3.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03. | |
| Latest headline from finance.yahoo.com: Acquisition by Dean Li of 15087 shares of Merck at 56.04 subject to Rule 16b-3 |
- Analyzing Psyence's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Psyence's stock is overvalued or undervalued compared to its peers.
- Examining Psyence's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Psyence's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Psyence's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Psyence's pink sheet. These opinions can provide insight into Psyence's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Psyence Pink Sheet analysis
When running Psyence's price analysis, check to measure Psyence's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Psyence is operating at the current time. Most of Psyence's value examination focuses on studying past and present price action to predict the probability of Psyence's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Psyence's price. Additionally, you may evaluate how the addition of Psyence to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |